Implementation of the 70 gene good/poor prognosis and 21-gene recurrence assays on NKI data resulted in highly significant prognosis predictions (Additional File 7 , Figure S4) suggesting that the current dataset represents tumors with similar clinical characteristics as previous tumor datasets.
← all excerpts
Systematic bias in genomic classification due to contaminating non-neoplastic tissue in breast tumor samples.
1
—
—